EXPIRATORY RESERVE VOLUME INCREASED

This adverse event was reported 3 times

These drugs are most commonly taken by patients reporting EXPIRATORY RESERVE VOLUME INCREASED:

# Drug Count
0 TIOTROPIUM BROMIDE 2
1 ALBUTEROL SULFATE 1
2 ALENDRONATE SODIUM 1
3 ALENDRONATE SODIUM TABLET 1
4 ASPIRIN 1
5 ASPIRIN 325 MG 1
6 ASPIRIN 81 MG 1
7 BUMETANIDE 1
8 CHOLESTERINUM 1
9 CHOLESTEROL 1
See all common drugs associated with EXPIRATORY RESERVE VOLUME INCREASED

EXPIRATORY RESERVE VOLUME INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHOLESTERINUM 1 0.0009
1 ROFLUMILAST 1 0.0001
2 ALENDRONATE SODIUM TABLET 1 0.0001
3 HUMAN IMMUNOGLOBULIN G 1 0.0000
4 BUMETANIDE 1 0.0000
5 FULVESTRANT 1 0.0000
6 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 1 0.0000
7 MOMETASONE FUROATE 1 0.0000
8 GLIPIZIDE 1 0.0000
9 TIOTROPIUM BROMIDE 2 0.0000
See all drugs enriched for association with EXPIRATORY RESERVE VOLUME INCREASED

EXPIRATORY RESERVE VOLUME INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 1 0.0000
1 Estrogen Receptor Antagonist [EPC] 1 0.0000
2 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
3 Anti-IgE [EPC] 1 0.0000
4 Sulfonylurea [EPC] 1 0.0000
5 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
6 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
7 Loop Diuretic [EPC] 1 0.0000
8 Platelet Aggregation Inhibitor [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with EXPIRATORY RESERVE VOLUME INCREASED